title: [French Society for Biological Psychiatry and Neuropsychopharmacology task force. Formal consensus for the treatment of bipolar disorder: an update (2014)].
abstract: As part of a process to improve the quality of care, the French Society for Biological Psychiatry and Neuropsychopharmacology developed in 2010 formal consensus guidelines for the treatment of bipolar disorder. The evolution of therapeutic options available in France for the treatment of bipolar disorder has justified the update of this guideline. The purpose of this work was to provide an updated and ergonomic document to promote its use by clinicians. This update focuses on two of the six thematic previously published (acute treatment and long-term treatment). Aspects of the treatment of bipolar patients sparking debate and questions of clinicians (use of antidepressant, place of the bitherapy, interest of long-acting antipsychotics…) were also covered. Finally, we proposed graded recommendations taking into account specifically the risk-benefit balance of each molecule.
authors.affiliation: EA 7280, Psychiatrie d'adulte B, CHU de Clermont-Ferrand, université d'Auvergne, 63000 Clermont-Ferrand, France; Association française de psychiatrie biologique et neuropsychopharmacologie (AFPBN), centre hospitalier Sainte-Anne, 75674 Paris, France. Electronic address: isamalin@chu-clermontferrand.fr.
authors.forename: L
authors.initials: L
authors.lastname: Samalin
authors.affiliation: Association française de psychiatrie biologique et neuropsychopharmacologie (AFPBN), centre hospitalier Sainte-Anne, 75674 Paris, France; Inserm U1061, CHU de Montpellier, université de Montpellier, 34000 Montpellier, France.
authors.forename: S
authors.initials: S
authors.lastname: Guillaume
authors.affiliation: Association française de psychiatrie biologique et neuropsychopharmacologie (AFPBN), centre hospitalier Sainte-Anne, 75674 Paris, France; Inserm U1061, CHU de Montpellier, université de Montpellier, 34000 Montpellier, France.
authors.forename: P
authors.initials: P
authors.lastname: Courtet
authors.affiliation: Association française de psychiatrie biologique et neuropsychopharmacologie (AFPBN), centre hospitalier Sainte-Anne, 75674 Paris, France; CHRU Carémeau, 30029 Nîmes, France.
authors.forename: M
authors.initials: M
authors.lastname: Abbar
authors.affiliation: Sylia-Stat, 92340 Bourg-la-Reine, France.
authors.forename: S
authors.initials: S
authors.lastname: Lancrenon
authors.affiliation: EA 7280, Psychiatrie d'adulte B, CHU de Clermont-Ferrand, université d'Auvergne, 63000 Clermont-Ferrand, France; Association française de psychiatrie biologique et neuropsychopharmacologie (AFPBN), centre hospitalier Sainte-Anne, 75674 Paris, France.
authors.forename: P-M
authors.initials: PM
authors.lastname: Llorca
mesh_terms: D000208:Acute Disease; D000328:Adult; D001689:Biological Psychiatry; D001714:Bipolar Disorder / Q000188:drug therapy*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D005602:France; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D011600:Psychopharmacology; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment; D012955:Societies, Medical
chemical_list: D011619:Psychotropic Drugs
keywords: Bipolar disorder; Guidelines; Pharmacotherapy; Psychopharmacologie; Recommandations; Troubles bipolaires